Splenectomy, the surgical removal of the spleen, remains a safe and effective treatment option for certain people with myelofibrosis…
Articles by Steve Bryson PhD
Many adults living with myelofibrosis say that needing frequent blood transfusions for severe anemia — a medical condition marked…
The first data from a small early clinical trial show Jubilant Therapeutics‘ oral therapy candidate JBI-802 may be effective…
Circulating myeloblasts (CMB), a type of immature white blood cell commonly found in the bloodstream of people with myelofibrosis,…
Cero Therapeutics is expanding enrollment in an early clinical trial that’s testing its T-cell-based therapy candidate CER-1236, to now…
Combining the blood cancer therapy selinexor with Jakafi (ruxolitinib), an oral treatment approved for adults with myelofibrosis, outperformed Jakafi alone…